Titre : Cônes de croissance

Cônes de croissance : Questions médicales fréquentes

Termes MeSH sélectionnés :

Communication
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cônes de croissance : Questions médicales les plus fréquentes", "headline": "Cônes de croissance : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cônes de croissance : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-08", "dateModified": "2025-04-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cônes de croissance" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Axones", "url": "https://questionsmedicales.fr/mesh/D001369", "about": { "@type": "MedicalCondition", "name": "Axones", "code": { "@type": "MedicalCode", "code": "D001369", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.145" } } }, "about": { "@type": "MedicalCondition", "name": "Cônes de croissance", "alternateName": "Growth Cones", "code": { "@type": "MedicalCode", "code": "D020439", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michihiro Igarashi", "url": "https://questionsmedicales.fr/author/Michihiro%20Igarashi", "affiliation": { "@type": "Organization", "name": "Department of Neurochemistry and Molecular Cell Biology, School of Medicine and Graduate School of Medical/Dental Sciences, Niigata University, Niigata, 951-8510, Japan." } }, { "@type": "Person", "name": "Daniel M Suter", "url": "https://questionsmedicales.fr/author/Daniel%20M%20Suter", "affiliation": { "@type": "Organization", "name": "Department of Biological Sciences, Purdue University, West Lafayette, IN, USA. dsuter@purdue.edu." } }, { "@type": "Person", "name": "Yimin Zou", "url": "https://questionsmedicales.fr/author/Yimin%20Zou", "affiliation": { "@type": "Organization", "name": "Neurobiology Section, Biological Sciences Division, University of California San Diego, La Jolla, CA 92093 yzou@ucsd.edu." } }, { "@type": "Person", "name": "Jeffrey van Haren", "url": "https://questionsmedicales.fr/author/Jeffrey%20van%20Haren", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Snehal S Mahadik", "url": "https://questionsmedicales.fr/author/Snehal%20S%20Mahadik", "affiliation": { "@type": "Organization", "name": "Program in Molecular, Cellular, and Developmental Biology, Department of Molecular Biosciences, The University of Kansas, 1200 Sunnyside Avenue, 5049 Haworth Hall, Lawrence, KS 66045." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Technology for helping people with neuromotor, intellectual, and speech disabilities engage in leisure and communication activities: a proof-of-concept study.", "datePublished": "2024-10-18", "url": "https://questionsmedicales.fr/article/39417704", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MRR.0000000000000649" } }, { "@type": "ScholarlyArticle", "name": "Risk Factors for Disease Aggravation in Older Patients With Non-communicable Diseases: Interpretive Structural and Hierarchical Holographic Modelling.", "datePublished": "2024-10-07", "url": "https://questionsmedicales.fr/article/39373056", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jan.16503" } }, { "@type": "ScholarlyArticle", "name": "Fenestrated clipping of previously coiled posterior-superiorly projecting anterior communicating artery aneurysms: How I do it.", "datePublished": "2024-10-05", "url": "https://questionsmedicales.fr/article/39367893", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00701-024-06279-5" } }, { "@type": "ScholarlyArticle", "name": "Sbno1 mediates cell-cell communication between neural stem cells and microglia through small extracellular vesicles.", "datePublished": "2024-09-29", "url": "https://questionsmedicales.fr/article/39343943", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13578-024-01296-4" } }, { "@type": "ScholarlyArticle", "name": "Effectiveness of Message Framing Interventions on Improving Health Outcomes for Individuals in Diabetes Health Education Communication: A Systematic Review.", "datePublished": "2024-09-23", "url": "https://questionsmedicales.fr/article/39308309", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/phn.13423" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Neurones", "item": "https://questionsmedicales.fr/mesh/D009474" }, { "@type": "ListItem", "position": 4, "name": "Neurofibres", "item": "https://questionsmedicales.fr/mesh/D009412" }, { "@type": "ListItem", "position": 5, "name": "Axones", "item": "https://questionsmedicales.fr/mesh/D001369" }, { "@type": "ListItem", "position": 6, "name": "Cônes de croissance", "item": "https://questionsmedicales.fr/mesh/D020439" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cônes de croissance - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cônes de croissance", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-04-30", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cônes de croissance", "description": "Comment identifier un cône de croissance ?\nQuels tests sont utilisés pour étudier les cônes de croissance ?\nLes cônes de croissance peuvent-ils être visualisés in vivo ?\nQuels marqueurs sont utilisés pour les cônes de croissance ?\nPeut-on évaluer la fonction des cônes de croissance ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Communication&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cônes de croissance", "description": "Quels symptômes indiquent un dysfonctionnement des cônes de croissance ?\nLes cônes de croissance affectent-ils le comportement ?\nComment les cônes de croissance sont-ils liés à la douleur ?\nLes troubles de la croissance neuronale causent-ils des symptômes physiques ?\nLes symptômes neurologiques sont-ils toujours présents avec des cônes de croissance anormaux ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Communication&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cônes de croissance", "description": "Peut-on prévenir les anomalies des cônes de croissance ?\nQuel rôle joue l'environnement dans le développement des cônes de croissance ?\nLes facteurs génétiques influencent-ils les cônes de croissance ?\nComment le stress maternel impacte-t-il le développement neuronal ?\nLes vaccinations influencent-elles le développement neuronal ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Communication&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cônes de croissance", "description": "Quels traitements existent pour les troubles liés aux cônes de croissance ?\nLa chirurgie peut-elle corriger des anomalies des cônes de croissance ?\nLes médicaments peuvent-ils aider à la régénération des cônes de croissance ?\nY a-t-il des thérapies innovantes pour les cônes de croissance ?\nComment la réhabilitation aide-t-elle les patients ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Communication&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cônes de croissance", "description": "Quelles complications peuvent survenir avec des cônes de croissance anormaux ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications peuvent-elles être prévenues ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Communication&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cônes de croissance", "description": "Quels sont les facteurs de risque pour les anomalies des cônes de croissance ?\nLe tabagisme maternel est-il un facteur de risque ?\nL'exposition à des toxines affecte-t-elle les cônes de croissance ?\nLes troubles génétiques augmentent-ils le risque ?\nLe manque de soins prénatals est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Communication&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un cône de croissance ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'observation microscopique des neurones en culture permet d'identifier les cônes de croissance." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour étudier les cônes de croissance ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme la microscopie à fluorescence et l'immunohistochimie sont couramment utilisées." } }, { "@type": "Question", "name": "Les cônes de croissance peuvent-ils être visualisés in vivo ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques d'imagerie avancées permettent de visualiser les cônes de croissance in vivo." } }, { "@type": "Question", "name": "Quels marqueurs sont utilisés pour les cônes de croissance ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme la tubuline et la protéine GAP-43 sont souvent utilisés pour les identifier." } }, { "@type": "Question", "name": "Peut-on évaluer la fonction des cônes de croissance ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests fonctionnels mesurent la capacité des cônes à diriger la croissance axonale." } }, { "@type": "Question", "name": "Quels symptômes indiquent un dysfonctionnement des cônes de croissance ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans la croissance neuronale peuvent entraîner des troubles neurologiques." } }, { "@type": "Question", "name": "Les cônes de croissance affectent-ils le comportement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans leur développement peuvent influencer le comportement et les fonctions cognitives." } }, { "@type": "Question", "name": "Comment les cônes de croissance sont-ils liés à la douleur ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des cônes de croissance mal orientés peuvent contribuer à des douleurs neuropathiques." } }, { "@type": "Question", "name": "Les troubles de la croissance neuronale causent-ils des symptômes physiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles peuvent entraîner des déficits moteurs ou sensoriels selon la région affectée." } }, { "@type": "Question", "name": "Les symptômes neurologiques sont-ils toujours présents avec des cônes de croissance anormaux ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, mais des anomalies peuvent augmenter le risque de troubles neurologiques." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies des cônes de croissance ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies peuvent être évitées par une bonne nutrition et des soins prénatals." } }, { "@type": "Question", "name": "Quel rôle joue l'environnement dans le développement des cônes de croissance ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement enrichi peut favoriser un développement neuronal sain et fonctionnel." } }, { "@type": "Question", "name": "Les facteurs génétiques influencent-ils les cônes de croissance ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mutations génétiques peuvent affecter le développement et la fonction des cônes." } }, { "@type": "Question", "name": "Comment le stress maternel impacte-t-il le développement neuronal ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Le stress maternel peut nuire au développement des cônes de croissance et à la santé neuronale." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles le développement neuronal ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations ne nuisent pas au développement neuronal et sont essentielles pour la santé." } }, { "@type": "Question", "name": "Quels traitements existent pour les troubles liés aux cônes de croissance ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie physique, la médication et la rééducation neurologique." } }, { "@type": "Question", "name": "La chirurgie peut-elle corriger des anomalies des cônes de croissance ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, la chirurgie peut être envisagée pour corriger des malformations structurelles." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à la régénération des cônes de croissance ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments favorisent la régénération axonale et la plasticité neuronale." } }, { "@type": "Question", "name": "Y a-t-il des thérapies innovantes pour les cônes de croissance ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et cellulaires sont en cours d'étude pour améliorer la régénération neuronale." } }, { "@type": "Question", "name": "Comment la réhabilitation aide-t-elle les patients ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La réhabilitation aide à restaurer les fonctions perdues et à améliorer la qualité de vie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des cônes de croissance anormaux ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles neurologiques, des déficits moteurs et des douleurs chroniques." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être atténuées par des traitements précoces et appropriés." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent réduire la qualité de vie en limitant les activités quotidiennes." } }, { "@type": "Question", "name": "Les complications neurologiques sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications neurologiques sont courantes chez les patients avec des anomalies des cônes." } }, { "@type": "Question", "name": "Les complications peuvent-elles être prévenues ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être prévenues par un suivi médical régulier et des interventions précoces." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les anomalies des cônes de croissance ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des infections prénatales et des toxines environnementales." } }, { "@type": "Question", "name": "Le tabagisme maternel est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme pendant la grossesse augmente le risque d'anomalies du développement neuronal." } }, { "@type": "Question", "name": "L'exposition à des toxines affecte-t-elle les cônes de croissance ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines environnementales peut nuire au développement neuronal." } }, { "@type": "Question", "name": "Les troubles génétiques augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles génétiques sont associés à des anomalies dans le développement des cônes." } }, { "@type": "Question", "name": "Le manque de soins prénatals est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un manque de soins prénatals peut augmenter le risque de complications neurologiques." } } ] } ] }

Sources (10000 au total)

Risk Factors for Disease Aggravation in Older Patients With Non-communicable Diseases: Interpretive Structural and Hierarchical Holographic Modelling.

This study aimed to analyse and determine the risk factors of disease aggravation faced by older patients with non-communicable diseases (NCDs) and their interwoven correlations.... We employed a descriptive and cross-sectional study, which followed the STROBE guidelines for reporting.... We conducted a semi-structured in-depth interview with 26 older patients with NCDs from a hospital in Qingdao, China between July and August 2022 on the basis of the literature review. Then, we analys... We identified 30 risk factors from individual, interpersonal, organisational, community and policy levels. The hierarchical structure model constructed by interpretive structural modelling demonstrate... Risk factors causing disease aggravation amongst older patients with NCDs are diverse. To delay the progression of NCDs, we should comprehensively explore risk factors, interpret the root causes and e... Controlling risk factors is an effective measure to postpone disease aggravation. Through this study, we provide a scientific and comprehensive basis for clinical risk screening so that healthcare pro... Patients participated in interviews to supplement risk factors included in our study. Experts provided opinions on the inclusion, exclusion and modification of risk factors....

Fenestrated clipping of previously coiled posterior-superiorly projecting anterior communicating artery aneurysms: How I do it.

Anterior communicating artery (ACOM) aneurysms are among the most common aneurysms associated with aneurysmal subarachnoid hemorrhage (International Study of Unruptured Intracranial Aneurysms I (N Eng... The relevant surgical anatomy with illustration is presented. A video detailing our technique on an illustrative case is provided.... Surgical clipping of posterior-superiorly projecting ACOM aneurysms can require complex clip configurations. We describe the key steps of posterior-superiorly projecting ACOM aneurysm clipping through...

Sbno1 mediates cell-cell communication between neural stem cells and microglia through small extracellular vesicles.

Neural stem cells (NSCs) play a crucial role in the progress of ischemic stroke. Research on zebrafish embryonic demonstrates an association between Strawberry Notch 1 (Sbno1) and central nervous syst... Adeno-associated virus (AAV) was used for overexpression or knockdown of Sbno1 in vitro or in vivo. A mouse model of MCAO was established to evaluate the neuroprotective effects of AAV-Sbno1, includin... Our results showed that Sbno1 is highly expressed in the central nervous system, which plays a crucial role in regulating the proliferation of NSCs through the PI3k-Akt-GSK3β-Wnt/β-catenin signaling p... Our studies indicate that sbno1 promotes the proliferation of NSCs and enhances endogenous repairing through the PI3k-Akt-GSK3β-Wnt/β-catenin signaling pathway. Additionally, NSCs overexpressing sbno1...

Effectiveness of Message Framing Interventions on Improving Health Outcomes for Individuals in Diabetes Health Education Communication: A Systematic Review.

To identify the effects of message-framing interventions on improving health outcomes of individuals in diabetes health education communication.... Four electronic databases including Web of Science, PubMed, EMBASE, and the Cochrane Library were the search engines used. The period of literature search was from their inception until December 2023.... The review included 10 studies. Many studies have investigated multiple health outcomes. Of the seven studies that evaluated behavioral health-related outcomes, all studies (7/7, 100%) found a positiv... In diabetes health education communication, message framing of gain and loss framing has a positive effect on health outcomes for individuals. The advantage of the loss framing is more significant in ... When constructing a message to promote health outcomes for patients with diabetes, the message framing is worth applying, and the advantages of loss framing can be considered more.... PROSPERO registration ID: CRD42023445074. https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=445074....

Sex talks-experiences with and barriers to communication about sexuality with healthcare staff among patients with anxiety disorder in Denmark.

Previous research among diverse patient populations suggests that healthcare staff routinely do not talk about sexuality with their patients even when such talks are highly indicated and relevant.... In this study we sought to investigate how patients at outpatient anxiety clinics in Denmark experience sexual communication with healthcare staff and what barriers they encounter in this connection.... We employed a survey design from January 1, 2018, to June 30, 2019. In collaboration with 11 outpatient anxiety clinics in Denmark, patients with a primary diagnosis of panic disorder, social phobia, ... Outcomes included patients' experiences with and barriers to sexual communication with healthcare staff.... In total, 61% of the patients in this sample group found it relevant to talk to healthcare staff about sexuality but only 28% of the study patients had done so, of whom 83% reported this communication... The study results indicated a need for healthcare staff to routinely map out and address sexual matters in their clinical work with anxiety patients while bearing in mind the common patient barriers f... This study included a large clinical outpatient sample of anxiety patients and an extensive survey. However, the results may not be generalizable across all anxiety patients or patients in general.... The results of this study strongly indicate that a majority of anxiety patients find it both relevant and beneficial to discuss sexual matters with healthcare staff in connection with their anxiety tr...

Parent-child interaction at age 5 months: genetic and environmental contributions and associations with later socio-communicative development.

Characteristics of parent-child interaction (PCI) early in life have been associated with later development in the child. Twin studies can help to disentangle child contributions to parent-child inter... Infant twins from a community sample [354 monozygotic (MZ), 268 same-sex dizygotic (DZ)] were assessed in terms of PCI at age 5 months. We used the classical twin design to map the aetiology of severa... Heritability was below 20% for all the included PCI traits. Unique (nonshared) environmental influences substantially overlapped across several PCI scales, suggesting that idiosyncrasies linked to eac... This study maps the phenotypic and aetiological structure of PCI in early infancy and supports the view that parents' sensitive responsiveness towards their infant is associated with later development...

Written Mobility Communication in Acute Care Medical Wards: An Observational Study of Physical Therapists' and Nurses' Documentation Practice.

Low inpatient mobility is associated with poor hospital outcomes. Poor communication between clinicians has been identified as a barrier to improving mobility. Understanding how mobility is communicat... This cross-sectional observational study was conducted across 4 hospitals in an Australian health service. A survey of physical therapists and nurses identified preferred sources and content of writte... Questionnaires were completed by 85 physical therapists and 150 nurses. Twenty-two sources of documentation about mobility were identified. Preferences for sources and content varied between disciplin... Written mobility communication focused on mobility assistance and aids, rather than mobility levels or mobility goals, with poor completion and inconsistency within documentation. More complete and co... Physical therapists and nurses seek and document different content in a wide range of locations, leading to incomplete and inconsistent written documentation.Understanding and resolving these practice...

Oncology Nurses' Communication Practices and Challenges Towards Advance Care Planning: A Sequential Explanatory Mixed-Method Study.

This study aims to explore the practice of advance care planning (ACP) among Chinese oncology nurses and identify challenges influencing care provision.... A sequential explanatory mixed-method design was employed, comprising a quantitative phase to assess communication practices, followed by a qualitative phase to explore the challenges faced in ACP.... The study employed convenience sampling, including 532 oncology nurses from seven hospitals in northern China. Quantitative data were collected through a cross-sectional survey and the ACP communicati... Quantitative findings revealed a low frequency of ACP communication among Chinese oncology nurses. Qualitative analysis identified four themes: lack of optimal timing, passive engagement of patients o... The study concluded that identified challenges compromise the effectiveness of ACP practices among Chinese oncology nurses. Inadequate communication, limited interdisciplinary collaboration and policy... The findings underscore the need for targeted interventions to enhance nurses' communication skills, foster interdisciplinary collaboration and provide policy support. Such interventions are pivotal t... This study adhered to the Mixed Methods Article Reporting Standards.... No contributions from patients or the public were involved in this study....